3rd Annual Pediatric Medicine & Child Health Conference · 2026-07-10 · Pediatrics

Long-Term Neurodevelopmental Outcomes of Premature Infants Treated with Erythropoietin

Dr. Sarah Mitchell, Dr. Carlos Mendez
Boston Childrens Hospital, Hospital de Niños Buenos Aires

View on AAMS · All conferences

Abstract

This multicenter study followed 420 extremely premature infants treated with high-dose EPO for 6 years. EPO-treated infants demonstrated significantly higher cognitive scores and lower rates of cerebral palsy (4.8% vs 12.3%).

Keywords: erythropoietin, premature infants, neurodevelopment, neuroprotection